论文部分内容阅读
目的:探讨主动脉内球囊反搏术在高危冠心病患者介入治疗中的临床效果。方法:15例高危冠心病患者实施冠脉介入治疗(PCI)时联合使用主动脉内球囊反搏术(IABP)进行辅助治疗,分析患者的临床特征、治疗效果。结果患者平均年龄、体重指数及合并高血压、糖尿病比例差异无统计学意义,使用主动脉内球囊反搏术的患者的有效率为86.67%,反搏后的血压明显高于反搏前的血压,差异有统计学意义(P<0.05)结论主动脉内球囊反搏术在治疗高危冠心病患者中具有很好的临床效果,可以改善患者血流动力学状况,有效降低高危冠心病患者冠脉介入治疗(PCI)的手术风险,提高手术的耐受性与成功率。
Objective: To investigate the clinical effect of intra-aortic balloon pump in the interventional treatment of high-risk patients with coronary heart disease. Methods: Fifteen patients with high risk coronary heart disease underwent coronary intervention (PCI) combined with intra-aortic balloon pump (IABP) for adjuvant therapy. The clinical features and therapeutic effects were analyzed. Results There was no significant difference in the mean age, body mass index and the proportion of patients with hypertension and diabetes mellitus. The effective rate was 86.67% in patients undergoing intra-aortic balloon pump. The blood pressure after counterpulsation was significantly higher than that before pre- (P <0.05). Conclusion Intra-aortic balloon pump is effective in treating high-risk patients with coronary heart disease, which can improve hemodynamic status and reduce the risk of coronary heart disease in high-risk patients Percutaneous coronary intervention (PCI) surgical risk, improve surgical tolerance and success rate.